Skip to main content
Top
Published in: Calcified Tissue International 4/2005

01-04-2005

Effects of Pleiotrophin (PTN) Over-expression on Mouse Long Bone Development, Fracture Healing and Bone repair

Authors: G. Li, J. R. Bunn, M. T. Mushipe, Q. He, X. Chen

Published in: Calcified Tissue International | Issue 4/2005

Login to get access

Abstract

Pleiotrophin (PTN) was found to have potent effects on regulation of osteoblast recruitment, proliferation and differentiation. The present study examined the long-term effects of targeted PTN over-expression on bone development and repair in a transgenic mouse model. Femurs and tibiae from the PTN transgenic mice and the wild type mice at age 1, 2, 4, 6, 12 and 24 months were collected, and examined by radiography, peripheral quantitative computed tomography (pQCT), histology and mechanical testing. Age-matched PTN and the control mice received a standardized femoral fracture, followed by regular x-rays and sacrificed at day 16 post-fracture for histology examination. A cortical hole was drilled on the tibiae of age-matched PTN and wild type mice, collagen sponge with either saline, 100 ng of rhBMP-2 or rhPTN was implanted in the holes, and animals were sacrificed 10 days later, subject to pQCT and histology examinations. During early stages of bone development, the PTN mice had advanced bone growth in length and maturation, but the difference diminished in later life. The fracture healing was impaired in the PTN mice, and there was delayed callus formation and remodelling. The cortical holes treated with BMP-2 in the PTN mice had significantly less trabecular bone formation. The current study confirmed that the targeted PTN over-expression in mouse bone has moderate enhancing effects on early bone development; but the bones become brittle in later life. Fracture healing was impaired in the adult PTN mice and this may be due to inhibitory effects of PTN over-expression on BMP-2 mediated bone induction.
Literature
1.
go back to reference Li, YS, Milner, PG, Chauhan, AK, et al. 1990Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activityScience25016901694CrossRef Li, YS, Milner, PG, Chauhan, AK,  et al. 1990Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activityScience25016901694CrossRef
2.
go back to reference Rauvala, H 1989An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factorsEMBO J829332941CrossRef Rauvala, H 1989An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factorsEMBO J829332941CrossRef
3.
go back to reference Vacherot, F, Delbe, J, Heroult, M, Barritault, D, Fernig, DG, Courty, J 1999Glycosaminoglycans differentially bind HARP and modulate its biological activityJ Biol Chem27477417747CrossRef Vacherot, F, Delbe, J, Heroult, M, Barritault, D, Fernig, DG, Courty, J 1999Glycosaminoglycans differentially bind HARP and modulate its biological activityJ Biol Chem27477417747CrossRef
4.
go back to reference Tezuka, K, Takeshita, S, Hakeda, Y, Kumegawa, M, Kikuno, R, Hashimoto-Gotoh, T 1990Isolation of mouse and human cDNA clones encoding a protein expressed specifically in osteoblasts and brain tissuesBiochem Biophys Res Commun173246251CrossRef Tezuka, K, Takeshita, S, Hakeda, Y, Kumegawa, M, Kikuno, R, Hashimoto-Gotoh, T 1990Isolation of mouse and human cDNA clones encoding a protein expressed specifically in osteoblasts and brain tissuesBiochem Biophys Res Commun173246251CrossRef
5.
go back to reference Hampton, BS, Marshak, DR, Burgess, WH 1992Structural and functional characterization of full-length heparin-binding growth associated moleculeMol Biol Cell38593CrossRef Hampton, BS, Marshak, DR, Burgess, WH 1992Structural and functional characterization of full-length heparin-binding growth associated moleculeMol Biol Cell38593CrossRef
6.
go back to reference Deuel, TF, Zhang, N, Yeh, HJ, Silos-Santiago, I, Wang, ZY 2002Pleiotrophin: a cytokine with diverse functions and a novel signaling pathwayArch Biochem Biophys397162171CrossRef Deuel, TF, Zhang, N, Yeh, HJ, Silos-Santiago, I, Wang, ZY 2002Pleiotrophin: a cytokine with diverse functions and a novel signaling pathwayArch Biochem Biophys397162171CrossRef
7.
go back to reference Imai, S, Kaksonen, M, Raulo, E, et al. 1998Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM)J Cell Biol14311131128CrossRef Imai, S, Kaksonen, M, Raulo, E,  et al. 1998Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM)J Cell Biol14311131128CrossRef
8.
go back to reference Tare, RS, Oreffo, RO, Clarke, NM, Roach, HI 2002Pleiotrophin/Osteoblast-stimulating factor 1: dissecting its diverse functions in bone formationJ Bone Miner Res1720092020CrossRef Tare, RS, Oreffo, RO, Clarke, NM, Roach, HI 2002Pleiotrophin/Osteoblast-stimulating factor 1: dissecting its diverse functions in bone formationJ Bone Miner Res1720092020CrossRef
9.
go back to reference Masuda, H, Tsujimura, A, Yoshioka, M, et al. 1997Bone mass loss due to estrogen deficiency is compensated in transgenic mice overexpressing human osteoblast stimulating factor-1Biochem Biophys Res Commun238528533CrossRef Masuda, H, Tsujimura, A, Yoshioka, M,  et al. 1997Bone mass loss due to estrogen deficiency is compensated in transgenic mice overexpressing human osteoblast stimulating factor-1Biochem Biophys Res Commun238528533CrossRef
10.
go back to reference Tare, RS, Oreffo, RO, Sato, K, Rauvala, H, Clarke, NM, Roach, HI 2002Effects of targeted overexpression of pleiotrophin on postnatal bone developmentBiochem Biophys Res Commun298324332CrossRef Tare, RS, Oreffo, RO, Sato, K, Rauvala, H, Clarke, NM, Roach, HI 2002Effects of targeted overexpression of pleiotrophin on postnatal bone developmentBiochem Biophys Res Commun298324332CrossRef
11.
go back to reference Connolly, CK, Li, G, Bunn, JR, Mushipe, M, Dickson, GR, Marsh, DR 2003A reliable externally fixated murine femoral fracture model that accounts for variation in movement between animalsJ Orthop Res21843849CrossRef Connolly, CK, Li, G, Bunn, JR, Mushipe, M, Dickson, GR, Marsh, DR 2003A reliable externally fixated murine femoral fracture model that accounts for variation in movement between animalsJ Orthop Res21843849CrossRef
12.
go back to reference Li, G, White, G, Connolly, C, Marsh, D 2002Cell proliferation and apoptosis during fracture healingJ Bone Miner Res17791799CrossRef Li, G, White, G, Connolly, C, Marsh, D 2002Cell proliferation and apoptosis during fracture healingJ Bone Miner Res17791799CrossRef
13.
go back to reference Raulo, E, Chernousov, MA, Carey, DJ, Nolo, R, Rauvala, H 1994Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3)J Biol Chem2691299913004PubMed Raulo, E, Chernousov, MA, Carey, DJ, Nolo, R, Rauvala, H 1994Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3)J Biol Chem2691299913004PubMed
14.
go back to reference Yang, X, Tare, RS, Partridge, KA, et al. 2003Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for tissue engineeringJ Bone Miner Res184757CrossRef Yang, X, Tare, RS, Partridge, KA,  et al. 2003Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for tissue engineeringJ Bone Miner Res184757CrossRef
15.
go back to reference Rauvala, H, Huttunen, HJ, Hages, C, et al. 2000Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motilityMatrix Biol19377387CrossRef Rauvala, H, Huttunen, HJ, Hages, C,  et al. 2000Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motilityMatrix Biol19377387CrossRef
Metadata
Title
Effects of Pleiotrophin (PTN) Over-expression on Mouse Long Bone Development, Fracture Healing and Bone repair
Authors
G. Li
J. R. Bunn
M. T. Mushipe
Q. He
X. Chen
Publication date
01-04-2005
Publisher
Springer New York
Published in
Calcified Tissue International / Issue 4/2005
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-004-0145-6

Other articles of this Issue 4/2005

Calcified Tissue International 4/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.